Medicus Pharma (NASDAQ:MDCX) Receives Buy Rating from D. Boral Capital

D. Boral Capital restated their buy rating on shares of Medicus Pharma (NASDAQ:MDCX) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $27.00 price objective on the stock.

Other research analysts have also recently issued reports about the company. Zacks Research upgraded Medicus Pharma to a “hold” rating in a report on Monday, September 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Medicus Pharma in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $23.50.

Medicus Pharma Stock Performance

MDCX opened at $2.30 on Wednesday. Medicus Pharma has a one year low of $1.79 and a one year high of $8.94. The stock has a market capitalization of $40.99 million and a PE ratio of -1.72. The business’s 50 day moving average price is $2.34 and its 200 day moving average price is $3.11.

Medicus Pharma (NASDAQ:MDCX) last released its quarterly earnings data on Monday, August 11th. The company reported ($0.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). As a group, equities research analysts forecast that Medicus Pharma will post -1.14 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Wilmington Savings Fund Society FSB acquired a new position in Medicus Pharma during the third quarter worth $59,000. Brave Asset Management Inc. acquired a new position in Medicus Pharma during the third quarter worth $46,000. Osaic Holdings Inc. lifted its stake in Medicus Pharma by 180.0% during the second quarter. Osaic Holdings Inc. now owns 14,000 shares of the company’s stock worth $42,000 after purchasing an additional 9,000 shares in the last quarter. Jane Street Group LLC acquired a new position in Medicus Pharma during the second quarter worth $41,000. Finally, May Hill Capital LLC acquired a new position in Medicus Pharma during the second quarter worth $107,000.

About Medicus Pharma

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.